Search

AngioDynamics Inc

Fermé

SecteurSoins de santé

15.75 0.7

Résumé

Variation du prix de l'action

24h

Actuel

Min

15.59

Max

15.71

Chiffres clés

By Trading Economics

Revenu

-3.3M

-11M

Ventes

8.2M

87M

BPA

-0.07

Marge bénéficiaire

-13.169

Employés

632

EBITDA

-26M

-28M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+33.84% upside

Dividendes

By Acuity

Prochains Résultats

1 oct. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

99M

627M

Ouverture précédente

15.05

Clôture précédente

15.75

Sentiment de l'Actualité

By Acuity

50%

50%

116 / 340 Classement par Healthcare

AngioDynamics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

7 août 2026, 19:33 UTC

News

AngioDynamics shares are rising despite a downgrade to Q3 2028 earnings estimates. Analysts from Canaccord Genuity and HC Wainwright raised their price targets.

6 août 2026, 19:56 UTC

AngioDynamics shares are lower during Thursday's session, with no specific news identified. The stock remains above its 20-day moving average.

5 août 2026, 19:46 UTC

AngioDynamics Inc shares are lower amid broader market caution following ADP's report of only 44,000 private sector jobs added in July.

4 août 2026, 19:31 UTC

AngioDynamics Inc shares are lower today, driven by significant declines in the Health Care Equipment sub-sector. No specific company news was identified.

3 août 2026, 20:02 UTC

AngioDynamics Inc shares are higher today, supported by gains in the Health Care Equipment sector. The stock remains above its 20-day moving average.

31 juil. 2026, 19:33 UTC

AngioDynamics shares are lower amid broader market dynamics and rising bond yields, despite remaining above the 20-day moving average.

30 juil. 2026, 18:56 UTC

AngioDynamics Inc. shares are trading roughly flat, remaining above their 20-day moving average after four consecutive sessions of higher closes.

29 juil. 2026, 19:56 UTC

Macro Event

AngioDynamics Inc shares are higher since Tuesday, reflecting volatility from the Federal Reserve's interest rate decision and easing inflation data.

28 juil. 2026, 20:02 UTC

News

AngioDynamics will participate in two investor conferences this week, contributing to a notable increase in shares during Tuesday's session.

27 juil. 2026, 19:56 UTC

AngioDynamics Inc is rising amid strength in the health care equipment sector. The stock reached a peak earlier in the session before moderating gains.

24 juil. 2026, 18:36 UTC

AngioDynamics Inc is trading higher today, reflecting a positive market response. The stock remains above its 20-day moving average amid no specific news.

23 juil. 2026, 20:03 UTC

AngioDynamics Inc. shares are lower today, reflecting a decline from Wednesday's close amid broader market weakness in tech stocks related to rising AI capital expenditures.

22 juil. 2026, 19:56 UTC

AngioDynamics Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. The stock remains above its 20-day moving average.

21 juil. 2026, 20:06 UTC

News

AngioDynamics Inc shares are higher today, supported by a strong Nasdaq 100 Index. Analysts maintain a Hold rating amid optimism for NanoKnife technology.

20 juil. 2026, 19:46 UTC

News

AngioDynamics shares are higher today, despite a downgrade to "strong sell" from Zacks Research and a price target increase from Canaccord Genuity to $20.00.

Comparaison

Variation de prix

AngioDynamics Inc prévision

Objectif de Prix

By TipRanks

33.84% hausse

Prévisions sur 12 Mois

Moyen 21 USD  33.84%

Haut 24 USD

Bas 19 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

3 ratings

3

Achat

0

Maintien

0

Vente

Sentiment

By Acuity

116 / 340Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.
help-icon Live chat